Five more AI-powered health clinics open in Phoenix grocery stores

Arizona-based telehealth company Akos has opened five additional AI-powered health clinics at Phoenix-area grocery stores in a continued push to provide better access to healthcare, the company recently announced.

In November, Akos launched virtual health clinics at five Safeway grocery stores in Phoenix, Gilbert, Glendale, Mesa and Tempe, Arizona. The newest clinics opened in Scottsdale (two), Ahwatukee, Chandler and Laveen. Two more clinics are also expected to open in Casa Grande, Arizona, and Boise, Idaho, by the end of March.

“Our hope is that these clinics help improve access to healthcare in the neighborhoods where we have these locations because they are located in the same place our customers are already buying groceries and picking up their prescriptions,” Joe Leyba, director of pharmacy for Albertsons Companies Southwest, which operates Safeway stores, said in a statement.

The clinics offer feature virtual and onsite health professionals and leverage AI and augmented reality (AR) to guide patients through the entire diagnostic process—including collecting patient information, automatically recording information into an electronic medical record (EMR), suggesting health and treatment options, verifying information with physicians and scheduling follow-up visits.

“Patients have expressed satisfaction at the ease and speed of the experience at the five locations we’ve had open since early November,” James Bates, president and CEO of Akos Med Clinic, said in a statement. “Like many other things, Artificial Intelligence is changing how we consume healthcare, and our AI system is giving time back to providers to spend consulting with patients.”

The virtual health clinic concept is similar to recent efforts by CVS Health to turn its retail stores into healthcare hubs for residents in the communities it serves.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.